OPKO HEALTH, INC.

OPK is the ticker symbol for OPKO HEALTH, INC., a publicly traded US company.

OPKO Health Inc is a diversified biotechnology company that operates pharmaceutical and diagnostic development programs. Its segments include pharmaceutical and diagnostics. The Pharmaceutical segment consists of its pharmaceutical operations in Chile, Mexico, Ireland, Israel, Spain, Ecuador, France, the United States, and its pharmaceutical research and development operations. The Diagnostics segment consists of clinical and genomics laboratory operations through BioReference and point-of-care operations. It generates the majority of its revenue from the Diagnostics segment.

Key metrics include a return on equity of -4.5%, a debt-to-equity ratio of 0.54.

The company reports trailing twelve-month revenue of $124.20M and net loss of $54.85M.

FINOTAUR aggregates real-time and fundamental data on OPK to help traders and investors make informed decisions. Track OPK in your trading journal alongside other positions for a unified view of your portfolio.